Erlotinib Unknown Status Phase 3 Trials for Esophageal Squamous Carcinoma Treatment

IndicationsStatusPurposePhase
Unknown StatusTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT01752205Paclitaxel Plus Radiation With Erlotinib to Treat Esophageal Squamous Carcinoma